{"product_id":"ucsf-addiction-conference-2026","title":"UCSF Addiction Conference 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: psychiatrists, primary care physicians, and addiction specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe UCSF Addiction Conference 2026 provides a comprehensive, evidence-based update on the clinical management of substance use disorders. The program equips healthcare providers with the latest strategies in pharmacology, behavioral therapies, and harm reduction to effectively diagnose, treat, and support patients dealing with various forms of addiction and co-occurring mental health conditions.\u003c\/p\u003e\n\u003ch3\u003eTopics covered will include:\u003c\/h3\u003e\n\u003cp\u003eKeynote address from a person with lived experience of Substance Use Disorder (SUD)\u003c\/p\u003e\n\u003cp\u003eSUD as a brain disease\u003c\/p\u003e\n\u003cp\u003eStigma around Opioid Use Disorder, including starting buprenorphine and methadone\u003c\/p\u003e\n\u003cp\u003eAlcohol Use Disorder\u003c\/p\u003e\n\u003cp\u003eBenzodiazepine Use Disorder and withdrawal management\u003c\/p\u003e\n\u003cp\u003eStimulant Use Disorder\u003c\/p\u003e\n\u003cp\u003ePregnancy and SUDs\u003c\/p\u003e\n\u003cp\u003ePain and SUDs\u003c\/p\u003e\n\u003cp\u003eHospital based care for patients with SUDs\u003c\/p\u003e\n\u003cp\u003eCommunication and documentation in caring for patients with SUDs\u003c\/p\u003e\n\u003cp\u003eLearning Objectives\u003c\/p\u003e\n\u003cp\u003eApply new knowledge to better recognize substance use disorders (SUD), including through use of the DSM-5 criteria for SUD\u003c\/p\u003e\n\u003cp\u003eOffer evidence-based medical and\/or behavioral treatments for opioid, alcohol, and stimulant use disorders\u003c\/p\u003e\n\u003cp\u003eApply communication strategies for more effective individual and team care of patients with SUD\u003c\/p\u003e\n\u003cp\u003eTarget Audience\u003c\/p\u003e\n\u003cp\u003eBest for psychiatrists, primary care physicians, and addiction specialists who want updates on substance use disorder treatments.\u003c\/p\u003e\n\u003cp\u003eTopics\u003c\/p\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cp\u003eApr 23_Day 1 AM\u003c\/p\u003e\n\u003cp\u003eApr 23_Day 1 PM\u003c\/p\u003e\n\u003cp\u003eApr 24_Day 2 AM\u003c\/p\u003e\n\u003cp\u003eApr 24_Day 2 PM\u003c\/p\u003e\n\u003ch3\u003e* Detail:\u003c\/h3\u003e\n\u003cp\u003eApril 23, 2026\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eWelcome from the Conference Chairs\u003c\/p\u003e\n\u003cp\u003e8:05 AM\u003c\/p\u003e\n\u003cp\u003eKeynote Address\u003c\/p\u003e\n\u003cp\u003e8:45 AM\u003c\/p\u003e\n\u003cp\u003eStigma and Clinical Diagnosis of Substance Use Disorders\u003c\/p\u003e\n\u003cp\u003e9:15 AM\u003c\/p\u003e\n\u003cp\u003eOUD Diagnosis and Methadone Induction\u003c\/p\u003e\n\u003cp\u003e10:15 AM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:30 AM\u003c\/p\u003e\n\u003cp\u003eComplex Buprenorphine Inductions\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003eTransition into Small Groups\u003c\/p\u003e\n\u003cp\u003e11:35 AM\u003c\/p\u003e\n\u003cp\u003eCase 1: Group Discussion\u003c\/p\u003e\n\u003cp\u003e12:15 PM\u003c\/p\u003e\n\u003cp\u003eLunch\u003c\/p\u003e\n\u003cp\u003e1:15 PM\u003c\/p\u003e\n\u003cp\u003e1:40 PM\u003c\/p\u003e\n\u003cp\u003eCannabis Use and Use Disorder for Adolescents and Adults\u003c\/p\u003e\n\u003cp\u003e2:40 PM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e2:55 PM\u003c\/p\u003e\n\u003cp\u003eStimulants and Drug Involved Deaths\u003c\/p\u003e\n\u003cp\u003e3:55 PM\u003c\/p\u003e\n\u003cp\u003eAlcohol Use Disorder: Diagnosis and Treatment\u003c\/p\u003e\n\u003cp\u003e4:55 PM\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e\n\u003cp\u003eApril 24, 2026\u003c\/p\u003e\n\u003cp\u003e8:00 AM\u003c\/p\u003e\n\u003cp\u003eWelcome from the Conference Chairs\u003c\/p\u003e\n\u003cp\u003e8:05 AM\u003c\/p\u003e\n\u003cp\u003eCommunication with Patients who use Substances\u003c\/p\u003e\n\u003cp\u003e8:55 AM\u003c\/p\u003e\n\u003cp\u003eBenzodiazpeine Use Disorder and Detoxification\u003c\/p\u003e\n\u003cp\u003e9:45 AM\u003c\/p\u003e\n\u003cp\u003ePotporri: Kratom, emerging NPS\u003c\/p\u003e\n\u003cp\u003e10:15 AM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e10:30 AM\u003c\/p\u003e\n\u003cp\u003eHospital Based care for patients with SUD including Opioid Withdrawal Mangement\u003c\/p\u003e\n\u003cp\u003e11:30\u003c\/p\u003e\n\u003cp\u003eTransition into Small Groups\u003c\/p\u003e\n\u003cp\u003e11:35 AM\u003c\/p\u003e\n\u003cp\u003eCase 2: Group Discussion\u003c\/p\u003e\n\u003cp\u003e12:15 PM\u003c\/p\u003e\n\u003cp\u003eLunch\u003c\/p\u003e\n\u003cp\u003e1:15 PM\u003c\/p\u003e\n\u003cp\u003e1:40 PM\u003c\/p\u003e\n\u003cp\u003eTelehealth and Patient centered Documentation\u003c\/p\u003e\n\u003cp\u003e2:40 PM\u003c\/p\u003e\n\u003cp\u003eBreak\u003c\/p\u003e\n\u003cp\u003e2:55 PM\u003c\/p\u003e\n\u003cp\u003eControlled Substances and SUD\u003c\/p\u003e\n\u003cp\u003e3:55 PM\u003c\/p\u003e\n\u003cp\u003ePregnancy and SUD\u003c\/p\u003e\n\u003cp\u003e4:55 PM\u003c\/p\u003e\n\u003cp\u003eClosing Remarks\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405753536708,"sku":null,"price":78.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/UCSF-Addiction-Conference-2026.jpg?v=1784215695","url":"https:\/\/medicalcoursespro.com\/products\/ucsf-addiction-conference-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}